Treatable traits in asthma: moving beyond diagnostic labels.

Authors:
McDonald VM; Gibson PG.

Journal:
Med J Aust

Publication Year: 2022

DOI:
10.5694/mja2.51464

PMCID:
PMC9313553

PMID:
35342966

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Med J Aust

Abbreviation: Med J Aust

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Medicine

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
Access to voluntary assisted dying in Australia requires fair remuneration for medical practitioner…
Haining CM; Willmott L; Towler S and 1 more (2022) - Transparency Score: 3/6
A planetary health-organ system map to integrate climate change and health content into medical cur…
Burch H; Beaton LJ; Simpson G and 3 more (2022) - Transparency Score: 2/6
A polymorphic rash from across the seas.
Flora A; Garg P; Cheung K and 2 more (2022) - Transparency Score: 2/6
Assessing the value of precision medicine health technologies to detect and manage melanoma.
Mahumud RA; Janda M; Soyer HP and 3 more (2022) - Transparency Score: 3/6
Associations between COVID-19 and hospitalisation with respiratory and non-respiratory conditions: …
Rowe SL; Leder K; Dyson K and 10 more (2022) - Transparency Score: 3/6
View All Papers from This Journal
Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Competing interests Peter Gibson has received grants from the National Health and Medical Research Council, Medical Research Future Fund and GlaxoSmithKline. He reports honoraria from AstraZeneca, GlaxoSmithKline, Novartis, Chiesi and Sanofi for educational activities. Vanessa McDonald has received grants from the National Health and Medical Research Council, Medical Research Future Fund, GlaxoSmithKline and Ramaciotti. She reports honoraria from GlaxoSmithKline, AstraZeneca and Novartis for educational activities."

Evidence found in paper:

"Peter Gibson has received grants from the National Health and Medical Research Council, Medical Research Future Fund and GlaxoSmithKline. He reports honoraria from AstraZeneca, GlaxoSmithKline, Novartis, Chiesi and Sanofi for educational activities. Vanessa McDonald has received grants from the National Health and Medical Research Council, Medical Research Future Fund, GlaxoSmithKline and Ramaciotti. She reports honoraria from GlaxoSmithKline, AstraZeneca and Novartis for educational activities."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025